Liver Cancer Drug Market Poised to Reach US$ 17.2 Billion by 2033 Amid Rapid Advances in Targeted Therapies | Astute Analytica
The industry currently witnesses a paradigm shift toward combination regimens, where oral kinase inhibitors and immunotherapies act as synergistic pillars.…